Home

Steven L. Krill

CIK 1599743 · EVP & Chief Scientific Officer · last filed 2018-01-09

Steven L. Krill is an EVP & Chief Scientific Officer who has filed 10 SEC Form 4 insider transactions across 1 company since 2014. The most recent filing, for EGRX, was dated Jan 9, 2018. Across all open-market trades the lifetime net is −$7.0M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

10

Lifetime Open-Market Net

-$7.03M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted EVP & Chief Scientific Officer 3,000 $2.14 $6.4K -$7.03M 10 2018-01-09

Recent Filings

10 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-01-09 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) +3,000 $0 EDGAR
2017-03-24 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Mixed — -$1.01M EDGAR
2017-01-06 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) — $0 EDGAR
2017-01-04 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Mixed — -$2.65M EDGAR
2016-12-15 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Mixed — -$692.0K EDGAR
2016-12-02 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Mixed — -$432.1K EDGAR
2016-01-05 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) — $0 EDGAR
2015-06-18 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Mixed — -$732.8K EDGAR
2015-03-17 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) — $0 EDGAR
2014-08-27 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) — $0 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.